Meeder Advisory Services Inc. Invests $3.18 Million in Danaher Corporation $DHR

Meeder Advisory Services Inc. bought a new position in Danaher Corporation (NYSE:DHR) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,421 shares of the conglomerate’s stock, valued at approximately $3,183,000.

Several other institutional investors have also added to or reduced their stakes in the business. Meeder Asset Management Inc. purchased a new stake in shares of Danaher during the second quarter valued at $44,000. Citizens Financial Group Inc. RI bought a new position in Danaher in the second quarter worth approximately $4,197,000. Texas Capital Bank Wealth Management Services Inc purchased a new position in Danaher during the second quarter valued at $7,965,000. Cornerstone Advisors LLC purchased a new position in shares of Danaher during the 2nd quarter valued at about $6,196,000. Finally, Aegis Wealth Management LLC bought a new position in shares of Danaher in the second quarter worth approximately $200,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Citigroup started coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price for the company. Evercore reaffirmed an “outperform” rating and issued a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Piper Sandler began coverage on Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target for the company. Royal Bank Of Canada upped their price objective on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. Finally, TD Cowen lowered their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Price Performance

Danaher stock opened at $199.62 on Wednesday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a market cap of $140.33 billion, a price-to-earnings ratio of 35.46, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. The firm has a 50-day moving average of $193.74 and a two-hundred day moving average of $192.50. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same period in the previous year, the company posted $0.77 EPS. Danaher’s revenue was up 5.5% on a year-over-year basis. On average, research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.